Equity (Tables)

6 Months Ended

Mar. 31, 2021

Equity [Abstract]

Schedule of Stock-based Compensation Expense - By Award Type

The effect of recording stock-based compensation expense was as follows:

Stock-based Compensation Expense - by award type	For the three months ended March 31,				For the six months ended March 31,
(in thousands)	2021		2020		2021		2020
Employee stock options	$	1	$	4	$	2	$	9
Restricted stock units and awards	501		552		932		928
Performance stock units and awards	269		363		586		655
Employee stock purchase plan	84		46		173		93
Outside director equity awards and fees in common stock	67		80		132		161
Total stock-based compensation expense	$	922	$	1,045	$	1,825	$	1,846

Schedule of Stock-based Compensation Expense - By Expense Type

Stock-based Compensation Expense - by expense type	For the three months ended March 31,				For the six months ended March 31,
(in thousands)	2021		2020		2021		2020
Cost of revenue	$	203	$	202	$	344	$	338
Selling, general, and administrative	510		591		1,069		1,076
Research and development	209		252		412		432
Total stock-based compensation expense	$	922	$	1,045	$	1,825	$	1,846

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted net income (loss) per share:

Basic and Diluted Net Income (Loss) Per Share	For the three months ended March 31,				For the six months ended March 31,
(in thousands, except per share)	2021		2020		2021		2020
Numerator:
Income (Loss) from continuing operations	$	4,384	$	(5,081)	$	6,953	$	(6,416)
Undistributed earnings allocated to common shareholders for basic and diluted net income (loss) per share	4,384		(5,081)		6,953		(6,416)
Denominator:
Denominator for basic net income (loss) per share - weighted average shares outstanding	32,968		29,033		31,219		28,931
Denominator for fully diluted net (income) loss per share - weighted average shares outstanding	34,451		29,033		32,492		28,931
Net income (loss) per basic share	$	0.13	$	(0.18)	$	0.22	$	(0.22)
Net income (loss) per fully diluted share	$	0.13	$	(0.18)	$	0.21	$	(0.22)
Weighted average antidilutive options, unvested restricted stock units and awards, unvested performance stock units and ESPP shares excluded from the computation	1,536		2,161		1,331		1,704

Schedule of Common Stock Reserved for Future Issuances

As of March 31, 2021, we had common stock reserved for the following future issuances:

Future Issuances	Number of Common Stock Shares Available for Future Issuances
Exercise of outstanding stock options	30,732
Unvested restricted stock units and awards	1,967,291
Unvested performance stock units and awards (at 200% maximum payout)	1,934,000
Purchases under the employee stock purchase plan	186,197
Issuance of stock-based awards under the Equity Plans	1,826,518
Purchases under the officer and director share purchase plan	88,741
Total reserved	6,033,479